Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 1,501–1,550 of 1,704 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06468670	Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma	not yet recruiting	Phase 2	30	Fujian Cancer HospitalOTHER_GOV	0	Jun 21, 2024	clinicaltrials
NCT06456138	Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC	not yet recruiting	Phase 1 / Phase 2	60	Shanghai Chest HospitalOTHER	1	Jun 13, 2024	clinicaltrials